The University of California, Los Angeles (UCLA) has been awarded a $721,235 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The grant supports a 3-year computational analysis of electroencephalogram (EEG) data to identify biomarkers that can predict the emergence, treatment response, and relapse of infantile spasms in children with tuberous sclerosis complex. The research aims to leverage UCLA's expertise in neuroscience and medical imaging to develop an EEG-based diagnostic tool that can improve detection and management of this neurological disorder affecting military families and the broader population. As a prime grantee, UCLA will lead the research effort at its facilities in Los Angeles. This federal award aligns with the program's objectives to transform military health care through innovative biomedical investigations.
Generated 2/25/25, 4:58 AM